SHENZHEN, China, Aug. 6, 2012 /PRNewswire-Asia-FirstCall/-- Mindray Medical International Limited (MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012.

Highlights for Second Quarter 2012

"Despite the challenging environments in various international regions, we have once again achieved very solid performance in sales, profits and cash generation," commented Xu Hang, Mindray's chairman and co-chief executive officer. "All major geographical areas have delivered strong growth for the quarter. We are particularly encouraged by our good performance in developed markets, considering the volatility of those regions over the past year. We have also improved our gross margin and the healthy cash conversion cycle reflected our efforts in improving operational efficiency. In addition, we have launched new products in our IVD line and closed the orthopedics acquisition recently. Our reagent sales are continuing to accelerate. All of these are in line with the company's strategy to capture opportunities in the fast-growing consumable products markets. Going forward, we intend to prudentlydeploy our strong cashposition and continue to look for attractive investment opportunities worldwide."

SUMMARY Second Quarter 2012

(in $ millions, except per-share data)

Three Months Ended

June 30

2012

2011

% chg

Visit link:
Mindray Announces Second Quarter 2012 Financial Results